Treatment of venous thromboembolism with vitamin K antagonists

Thesis

Cover

Titlepage

CONTENTS

Chapter 1 General introduction

PART I Therapeutic quality control of treatment with vitamin K antagonists

Chapter 2 Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists

Chapter 3 Treatment with vitamin K antagonists for symptomatic venous thromboembolism Determinants of time spent in the therapeutic range

PART II Determinants of thromboembolic events and bleeding complications during treatment with vitamin K antagonists

Chapter 4 The incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved INR A retrospective analysis

Chapter 5 Safety of treatment with oral anticoagulants in the elderly A systematic review

Chapter 6 Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism

Chapter 7 Should patients with venous thromboembolism and cancer be treated differently?

PART III Duration of treatment with vitamin K antagonists

Chapter 8 Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Chapter 9 Long-term treatment of venous thromboembolic disease

Chapter 10 Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S A decision analysis

Summary

Samenvatting

Dankwoord

Curriculum Vitae

Stellingen behorende bij het proefschrift

Cover